Literature DB >> 23715847

An appraisal of lymph node ratio in colon and rectal cancer: not one size fits all.

M Medani1, Niall Kelly, George Samaha, G Duff, Vourneen Healy, Elizabeth Mulcahy, Eoghan Condon, David Waldron, Jean Saunders, J Calvin Coffey.   

Abstract

BACKGROUND: Lymph node ratio (LNR) is increasingly accepted as a useful prognostic indicator in colorectal cancer. However, variations in methodology, statistical stringency and cohort composition has led to inconsistency in respect of the optimally prognostic LNR.
OBJECTIVE: The aim was to apply a robust regression-based analysis to generate and appraise LNRs optimally prognostic for colon and rectal cancer, both separately and in combination.
METHODS: LNR was established for all patients undergoing either a colonic (n = 379) or rectal (n = 160) cancer resection with curative intent. The optimal LNR associated with disease-free and overall survival were established using a classification and regression tree technique. This process was repeated separately for patients who underwent either colonic or rectal resection and for the combined cohort. Survival associated with differing LNR was estimated using the Kaplan-Meier method and compared using a log-rank test. Relationships between LNR, disease-free survival (DFS) and overall survival (OS) were further characterised using Cox regression analysis. All statistical analyses were conducted in the R programming environment, with statistical significance was taken at a level of p < 0.05.
RESULTS: Optimal LNRs differed between each cohort, when either overall or disease-free survival was considered. LNRs generated from combined cohorts also differed from those generated by individual cohorts. In relation to DFS, LNR values were obtained and included 0.18 for the colon cancer cohort and 0.19 for the rectal and combined colorectal cancer cohorts. In relation to OS, multiple LNR values were obtained for colon and combined cohorts; however, an optimal LNR was not evident in the rectal cancer cohort. Survival patterns according to LNR closely resembled those associated with standard nodal staging.
CONCLUSION: Application of a data-driven approach based on recursive partitioning generates differing lymph node ratios for colon, rectal and combined colorectal cohorts. In each cohort, LNR was similarly prognostic to standard nodal staging in respect to overall and disease-free survival. Overall survival was associated with a multiplicity of LNR values, whilst disease-free survival was associated with a single LNR only. The paper demonstrates the merits of utilising a data-driven approach to determining lymph node ratios from specific patient cohorts. Utilising such an approach enabled the generation of those LNRs that were most associated with particular survival trends in relation to overall and disease-free survival. These differed markedly for colon cancer, rectal cancer and combined cohorts. In general, the survival patterns associated with LNRs generated were similar to those observed with standard nodal staging.

Entities:  

Mesh:

Year:  2013        PMID: 23715847     DOI: 10.1007/s00384-013-1707-8

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  40 in total

1.  Relationship of Ki-ras mutations in colon cancers to tumor location, stage, and survival: a population-based study.

Authors:  W S Samowitz; K Curtin; D Schaffer; M Robertson; M Leppert; M L Slattery
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-11       Impact factor: 4.254

2.  Ratio of metastatic to resected lymph nodes enhances to predict survival in patients with stage III colorectal cancer.

Authors:  Hai-Bo Qiu; Li-Yi Zhang; Yuan-Fang Li; Zhi-Wei Zhou; Rajiv Prasad Keshari; Rui-Hua Xu
Journal:  Ann Surg Oncol       Date:  2011-01-05       Impact factor: 5.344

3.  Patterns of lymph node metastasis are different in colon and rectal carcinomas.

Authors:  Hao Wang; Xian-Zhao Wei; Chuan-Gang Fu; Rong-Hua Zhao; Fu-Ao Cao
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

4.  Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons.

Authors:  Carlos A Vaccaro; Victor Im; Gustavo L Rossi; Guillermo Ojea Quintana; Mario L Benati; Diego Perez de Arenaza; Fernando A Bonadeo
Journal:  Dis Colon Rectum       Date:  2009-07       Impact factor: 4.585

5.  The prognostic value of lymph node ratio in a population-based collective of colorectal cancer patients.

Authors:  Robert Rosenberg; Jutta Engel; Christiane Bruns; Wolfgang Heitland; Nikolaus Hermes; Karl-Walter Jauch; Reinhard Kopp; Eberhard Pütterich; Reinhard Ruppert; Tibor Schuster; Helmut Friess; Dieter Hölzel
Journal:  Ann Surg       Date:  2010-06       Impact factor: 12.969

6.  The relationship between tumour site, clinicopathological characteristics and cancer-specific survival in patients undergoing surgery for colorectal cancer.

Authors:  A G M T Powell; R Wallace; R F McKee; J H Anderson; J J Going; J Edwards; P G Horgan
Journal:  Colorectal Dis       Date:  2012-12       Impact factor: 3.788

7.  Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered.

Authors:  N S Goldstein; W Sanford; M Coffey; L J Layfield
Journal:  Am J Clin Pathol       Date:  1996-08       Impact factor: 2.493

8.  Number of nodes examined and staging accuracy in colorectal carcinoma.

Authors:  J H Wong; R Severino; M B Honnebier; P Tom; T S Namiki
Journal:  J Clin Oncol       Date:  1999-09       Impact factor: 44.544

9.  Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period.

Authors:  Robert Rosenberg; Jan Friederichs; Tibor Schuster; Ralf Gertler; Matthias Maak; Karen Becker; Anne Grebner; Kurt Ulm; Heinz Höfler; Hjalmar Nekarda; Jörg-Rüdiger Siewert
Journal:  Ann Surg       Date:  2008-12       Impact factor: 12.969

10.  Absence of lymph nodes in the resected specimen after radical surgery for distal rectal cancer and neoadjuvant chemoradiation therapy: what does it mean?

Authors:  Angelita Habr-Gama; Rodrigo O Perez; Igor Proscurshim; Viviane Rawet; Diego D Pereira; Afonso H S Sousa; Desiderio Kiss; Ivan Cecconello
Journal:  Dis Colon Rectum       Date:  2008-03       Impact factor: 4.585

View more
  5 in total

1.  Prognostic influences of lymph node ratio in major cancers of Taiwan: a longitudinal study from a single cancer center.

Authors:  Yen-Lin Chen; Cheng-Yi Wang; Chin-Chia Wu; Moon-Sing Lee; Shih-Kai Hung; Wei-Chou Chen; Chih-Yao Hsu; Chia-Wen Hsu; Chih-Yuan Huang; Yu-Chieh Su; Ching-Chih Lee
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-29       Impact factor: 4.553

Review 2.  Assessment of lymph node involvement in colorectal cancer.

Authors:  Mark L H Ong; John B Schofield
Journal:  World J Gastrointest Surg       Date:  2016-03-27

Review 3.  Lymph node staging in colorectal cancer: old controversies and recent advances.

Authors:  Annika Resch; Cord Langner
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

4.  Increased lymph node yield in colorectal cancer is not necessarily associated with a greater number of lymph node positive cancers.

Authors:  Aisling O'Shea; Omar Aly; Craig N Parnaby; Malcolm A Loudon; Leslie M Samuel; Graeme I Murray
Journal:  PLoS One       Date:  2014-08-13       Impact factor: 3.240

5.  Prognostic Value of Lymph Node Ratio in Patients Receiving Combined Surgical Resection for Gastric Cancer Liver Metastasis: Results from Two National Centers in China.

Authors:  Mu-Xing Li; Zheng-Xiong Jin; Jian-Guo Zhou; Jian-Ming Ying; Zhi-Yong Liang; Xin-Xin Mao; Xin-Yu Bi; Jian-Jun Zhao; Zhi-Yu Li; Zhen Huang; Ye-Fan Zhang; Yuan Li; Xiao Chen; Xu-Hui Hu; Han-Jie Hu; Dong-Bing Zhao; Ying-Yi Wang; Jian-Qiang Cai; Hong Zhao
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.